Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.
Molero-Valenzuela A, de Rojas-P I, Pons G, Pérez-García MJ, Guillén G, Vilaplana A, Manresa-Vera S, Pérez-Albert P, Garrido M, Valero-Arrese L, Hladun R, Sánchez-Guixé M, Miera-Maluenda M, Boloix A, Roma J, Soriano A, Moreno L, Segura MF
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.